Open AccessDemonstration of Thiopurine Methyltransferase Activity in the Erythrocytes of Cats
Author(s) -
Foster Aiden P.,
Shaw Susan E.,
Duley John A.,
ShobowaleBakre ElMonsor,
Harbour David A.
Publication year - 2000
Publication title -
journal of veterinary internal medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.356
H-Index - 103
eISSN - 1939-1676
pISSN - 0891-6640
DOI - 10.1111/j.1939-1676.2000.tb02275.x
Subject(s) - thiopurine methyltransferase , cats , azathioprine , medicine , adverse effect , pharmacology , hemoglobin , whole blood , immunology , disease
Azathioprine is a purine analogue used as an immunosuppressive and immunomodulator agent in various mammals, including cats. Several adverse reactions have been reported and have limited the use of the drug in the cat. Adverse reactions to azathioprine in humans have been correlated with reduced activity of thiopurine methyltransferase (TPMT) in erythrocytes. The purpose of this preliminary study was to determine if cats have TPMT activity in their erythrocytes and to compare the values obtained with the normal range for humans and the normal range for dogs in a preliminary report. Activity of the enzyme was measured in blood samples drawn from 41 cats. Blood also was taken from 5 dogs. The mean erythrocyte TPMT activity in the cats was 2.4 ± 0.4 nmol (range, 1.2–3.9 nmol) per hour per milliliter of red blood cells (U/mL RBC) or 2–8 nmol per hour per gram of hemoglobin (U/g Hb). This range was far lower than the normal human range (8–15 U/mL RBC; 16–33 U/g Hb) and was of monopolar distribution. This observation apparently precludes any diagnostic purpose in assaying erythrocyte TPMT in this species. Erythrocyte TPMT activity in the 5 dogs ranged from 5.5 to 13.1 U/mL RBC (11–27 U/g Hb), which was comparable with normal and carrier ranges for humans, but proof of TPMT genetic polymorphism in either species will require genotyping studies.